Glioblastom (Swedish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Glioblastom" in Swedish language version.

refsWebsite

Global rank Swedish rank

8nih.gov

4^th place

17^th place

7doi.org

2^nd place

14^th place

3worldcat.org

5^th place

9^th place

2elsevier.com

610^th place

590^th place

1google.ca

838^th place

621^st place

1cancer.gov

1,684^th place

1,509^th place

1pnas.org

1,293^rd place

739^th place

1sciencemag.org

857^th place

496^th place

cancer.gov

”With Immunotherapy, Glimmers of Progress against Glioblastoma”. National Cancer Institute. 9 december 2015. http://www.cancer.gov/types/brain/research/immunotherapy-glioblastoma. Läst 23 december 2015.

doi.org

dx.doi.org

Bleeker, Fonnet E.; Molenaar, Remco J.; Leenstra, Sieger (2012). ”Recent advances in the molecular understanding of glioblastoma”. Journal of Neuro-Oncology 108 (1): sid. 11–27. doi:10.1007/s11060-011-0793-0. PMID 22270850.
McNeill, Katharine A.. ”Epidemiology of Brain Tumors”. Neurologic Clinics 34 (4): sid. 981–998. doi:10.1016/j.ncl.2016.06.014. http://linkinghub.elsevier.com/retrieve/pii/S0733861916300366. Läst 25 december 2016.
Van Meir, E. G.; Hadjipanayis, C. G.; Norden, A. D.; Shu, H. K.; Wen, P. Y.; Olson, J. J. (2010). ”Exciting New Advances in Neuro-Oncology: The Avenue to a Cure for Malignant Glioma”. CA: A Cancer Journal for Clinicians 60 (3): sid. 166–93. doi:10.3322/caac.20069. PMID 20445000.
Sottoriva, A.; Spiteri, I.; Piccirillo, S. G. M.; Touloumis, A.; Collins, V. P.; Marioni, J. C. (2013-03-05). ”Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics” (på engelska). Proceedings of the National Academy of Sciences 110 (10): sid. 4009–4014. doi:10.1073/pnas.1219747110. ISSN 0027-8424. http://www.pnas.org/cgi/doi/10.1073/pnas.1219747110. Läst 20 februari 2019.
Johnson, B. E.; Mazor, T.; Hong, C.; Barnes, M.; Aihara, K.; McLean, C. Y. (2014-01-10). ”Mutational Analysis Reveals the Origin and Therapy-Driven Evolution of Recurrent Glioma” (på engelska). Science 343 (6167): sid. 189–193. doi:10.1126/science.1239947. ISSN 0036-8075. PMID 24336570. PMC: PMC3998672. http://www.sciencemag.org/cgi/doi/10.1126/science.1239947. Läst 20 februari 2019.
Wang, Qianghu; Hu, Baoli; Hu, Xin; Kim, Hoon; Squatrito, Massimo; Scarpace, Lisa (2017-7). ”Tumor Evolution of Glioma-Intrinsic Gene Expression Subtypes Associates with Immunological Changes in the Microenvironment” (på engelska). Cancer Cell 32 (1): sid. 42–56.e6. doi:10.1016/j.ccell.2017.06.003. https://linkinghub.elsevier.com/retrieve/pii/S1535610817302532. Läst 20 februari 2019.
Alnahhas, Iyad; Alsawas, Mouaz; Rayi, Appaji; Palmer, Joshua D.; Raval, Raju; Ong, Shirley (2020). ”Characterizing benefit from temozolomide in MGMT promoter unmethylated and methylated glioblastoma: a systematic review and meta-analysis”. Neuro-Oncology Advances 2 (1): sid. vdaa082. doi:10.1093/noajnl/vdaa082. ISSN 2632-2498. PMID 33150334. PMC: 7596890. https://pubmed.ncbi.nlm.nih.gov/33150334. Läst 17 mars 2024.

elsevier.com

linkinghub.elsevier.com

McNeill, Katharine A.. ”Epidemiology of Brain Tumors”. Neurologic Clinics 34 (4): sid. 981–998. doi:10.1016/j.ncl.2016.06.014. http://linkinghub.elsevier.com/retrieve/pii/S0733861916300366. Läst 25 december 2016.
Wang, Qianghu; Hu, Baoli; Hu, Xin; Kim, Hoon; Squatrito, Massimo; Scarpace, Lisa (2017-7). ”Tumor Evolution of Glioma-Intrinsic Gene Expression Subtypes Associates with Immunological Changes in the Microenvironment” (på engelska). Cancer Cell 32 (1): sid. 42–56.e6. doi:10.1016/j.ccell.2017.06.003. https://linkinghub.elsevier.com/retrieve/pii/S1535610817302532. Läst 20 februari 2019.

google.ca

books.google.ca

Schapira, Anthony H.V. (2007). Neurology and clinical neuroscience. Philadelphia: Mosby Elsevier. sid. 1336. ISBN 9780323070539. https://books.google.ca/books?id=EwajBQAAQBAJ&pg=PA1336

nih.gov

ncbi.nlm.nih.gov

Bleeker, Fonnet E.; Molenaar, Remco J.; Leenstra, Sieger (2012). ”Recent advances in the molecular understanding of glioblastoma”. Journal of Neuro-Oncology 108 (1): sid. 11–27. doi:10.1007/s11060-011-0793-0. PMID 22270850.
Young, RM; Jamshidi, A; Davis, G; Sherman, JH (juni 2015). ”Current trends in the surgical management and treatment of adult glioblastoma.”. Annals of translational medicine 3 (9): sid. 121. PMID 26207249.
Gallego, O (augusti 2015). ”Nonsurgical treatment of recurrent glioblastoma.”. Current oncology (Toronto, Ont.) 22 (4): sid. e273-81. PMID 26300678.
Hart, MG; Garside, R; Rogers, G; Stein, K; Grant, R (30 april 2013). ”Temozolomide for high grade glioma.”. The Cochrane database of systematic reviews 4: sid. CD007415. PMID 23633341.
Van Meir, E. G.; Hadjipanayis, C. G.; Norden, A. D.; Shu, H. K.; Wen, P. Y.; Olson, J. J. (2010). ”Exciting New Advances in Neuro-Oncology: The Avenue to a Cure for Malignant Glioma”. CA: A Cancer Journal for Clinicians 60 (3): sid. 166–93. doi:10.3322/caac.20069. PMID 20445000.
Johnson, B. E.; Mazor, T.; Hong, C.; Barnes, M.; Aihara, K.; McLean, C. Y. (2014-01-10). ”Mutational Analysis Reveals the Origin and Therapy-Driven Evolution of Recurrent Glioma” (på engelska). Science 343 (6167): sid. 189–193. doi:10.1126/science.1239947. ISSN 0036-8075. PMID 24336570. PMC: PMC3998672. http://www.sciencemag.org/cgi/doi/10.1126/science.1239947. Läst 20 februari 2019.
Alnahhas, Iyad; Alsawas, Mouaz; Rayi, Appaji; Palmer, Joshua D.; Raval, Raju; Ong, Shirley (2020). ”Characterizing benefit from temozolomide in MGMT promoter unmethylated and methylated glioblastoma: a systematic review and meta-analysis”. Neuro-Oncology Advances 2 (1): sid. vdaa082. doi:10.1093/noajnl/vdaa082. ISSN 2632-2498. PMID 33150334. PMC: 7596890. https://pubmed.ncbi.nlm.nih.gov/33150334. Läst 17 mars 2024.

pubmed.ncbi.nlm.nih.gov

Alnahhas, Iyad; Alsawas, Mouaz; Rayi, Appaji; Palmer, Joshua D.; Raval, Raju; Ong, Shirley (2020). ”Characterizing benefit from temozolomide in MGMT promoter unmethylated and methylated glioblastoma: a systematic review and meta-analysis”. Neuro-Oncology Advances 2 (1): sid. vdaa082. doi:10.1093/noajnl/vdaa082. ISSN 2632-2498. PMID 33150334. PMC: 7596890. https://pubmed.ncbi.nlm.nih.gov/33150334. Läst 17 mars 2024.

pnas.org

Sottoriva, A.; Spiteri, I.; Piccirillo, S. G. M.; Touloumis, A.; Collins, V. P.; Marioni, J. C. (2013-03-05). ”Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics” (på engelska). Proceedings of the National Academy of Sciences 110 (10): sid. 4009–4014. doi:10.1073/pnas.1219747110. ISSN 0027-8424. http://www.pnas.org/cgi/doi/10.1073/pnas.1219747110. Läst 20 februari 2019.

sciencemag.org

Johnson, B. E.; Mazor, T.; Hong, C.; Barnes, M.; Aihara, K.; McLean, C. Y. (2014-01-10). ”Mutational Analysis Reveals the Origin and Therapy-Driven Evolution of Recurrent Glioma” (på engelska). Science 343 (6167): sid. 189–193. doi:10.1126/science.1239947. ISSN 0036-8075. PMID 24336570. PMC: PMC3998672. http://www.sciencemag.org/cgi/doi/10.1126/science.1239947. Läst 20 februari 2019.

worldcat.org

Sottoriva, A.; Spiteri, I.; Piccirillo, S. G. M.; Touloumis, A.; Collins, V. P.; Marioni, J. C. (2013-03-05). ”Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics” (på engelska). Proceedings of the National Academy of Sciences 110 (10): sid. 4009–4014. doi:10.1073/pnas.1219747110. ISSN 0027-8424. http://www.pnas.org/cgi/doi/10.1073/pnas.1219747110. Läst 20 februari 2019.
Johnson, B. E.; Mazor, T.; Hong, C.; Barnes, M.; Aihara, K.; McLean, C. Y. (2014-01-10). ”Mutational Analysis Reveals the Origin and Therapy-Driven Evolution of Recurrent Glioma” (på engelska). Science 343 (6167): sid. 189–193. doi:10.1126/science.1239947. ISSN 0036-8075. PMID 24336570. PMC: PMC3998672. http://www.sciencemag.org/cgi/doi/10.1126/science.1239947. Läst 20 februari 2019.
Alnahhas, Iyad; Alsawas, Mouaz; Rayi, Appaji; Palmer, Joshua D.; Raval, Raju; Ong, Shirley (2020). ”Characterizing benefit from temozolomide in MGMT promoter unmethylated and methylated glioblastoma: a systematic review and meta-analysis”. Neuro-Oncology Advances 2 (1): sid. vdaa082. doi:10.1093/noajnl/vdaa082. ISSN 2632-2498. PMID 33150334. PMC: 7596890. https://pubmed.ncbi.nlm.nih.gov/33150334. Läst 17 mars 2024.